Xinjiang's First Domestically Developed SPECT/CT Put into Operation at the First Affiliated Hospital of Shihezi University

Recently, the mid-term summary meeting of the National Key R&D Program project "Research on Application Solutions for Domestically Developed Dual-Head Single-Photon Imaging Equipment (SPECT)" under the 14th Five-Year Plan, along with the SPECT/CT commissioning ceremony and academic seminar, was held at the First Affiliated Hospital of Shihezi University. The Insight four-dimensional quantitative SPECT/CT from永新医疗 (Yongxin Medical) was officially installed in Xinjiang, becoming the first domestically developed SPECT/CT system put into clinical use in the region. A representative from the First Affiliated Hospital of Shihezi University stated that the commissioning of the domestically developed SPECT/CT will help the hospital improve its precision diagnosis and treatment system in northern Xinjiang and enhance regional nuclear medicine service capabilities. Experts attending the meeting noted that the deployment of this system in clinical practice will help explore the standardized application pathways of SPECT/CT in primary hospitals and accumulate clinical experience in the use of nuclear medicine imaging equipment in western China.

2026-08-03

Kangbuk Samsung Hospital in South Korea Validates Precision of New-Generation Surface-Guided Radiation Therapy System

The research team from the Department of Radiation Oncology at Kangbuk Samsung Hospital in South Korea announced on July 31 that they have completed validation of the geometric accuracy and respiratory tracking performance of a new-generation surface-guided radiation therapy system. The research findings have been published in the latest issue of the international academic journal *Radiation Physics and Chemistry*. In breast cancer radiotherapy, the deep inspiration breath-hold technique is commonly used in clinical practice to reduce radiation exposure to the heart and lungs. Traditional procedures typically require tattoo marks or drawn guide lines on the patient's skin surface, along with wearing sensors to monitor respiratory motion, which somewhat compromises treatment convenience and patient comfort. The new-generation surface-guided radiation therapy system validated in this study utilizes 3D stereoscopic cameras and thermal imaging technology...

2026-08-02

Egypt's Ministry of Health Advances Medical Radiation Safety Regulatory Review in Cooperation with IAEA

On July 31, Egypt's Ministry of Health and Population stated that it reaffirmed its critical role in improving Egypt's national radiation safety system during a 12-day Integrated Regulatory Review Service (IRRS) mission conducted by the International Atomic Energy Agency (IAEA). The IRRS mission, involving a team of international experts and reviewers, was conducted at the invitation of the Egyptian Nuclear and Radiological Regulatory Authority (ENRRA). Egyptian authorities stated that this step is part of the country's ongoing efforts to strengthen its national radiation safety framework and enhance its regulatory infrastructure in line with the latest international standards. The Ministry of Health and Population submitted a topical report through the Radiation Protection Executive Office of the General Department of Radiology, detailing its role in regulating and supervising the use of medical radiation...

2026-08-01

India's First Elekta Evo Installed at Manipal Hospital in Bengaluru for Online Adaptive Radiotherapy

Bengaluru, India – Manipal Hospital Yelahanka has become the first healthcare facility in India to install Elekta Evo, Elekta's AI-enhanced adaptive CT linac platform, which will support clinical teams in delivering online adaptive radiotherapy for more personalized and precise cancer treatment. The system was previously showcased at AROICON 2025, India's radiation oncology conference. According to data from the Indian Council of Medical Research, India records an estimated 1.46 million new cancer cases annually, with radiotherapy demand continuing to grow. For patients with complex conditions or those presenting at advanced stages...

2026-08-01

Anambra State, Nigeria Strengthens Cooperation with Nuclear Regulatory Authority to Enhance Safety Management of Medical Radioactive Materials

The Anambra State Government of Nigeria recently stated that it will strengthen cooperation with the Nigerian Nuclear Regulatory Authority (NNRA) to enhance radiation safety across the state and ensure the safe and compliant use of radioactive materials in medical institutions. At a meeting held in Awka, the capital of Anambra State, Dr. Afam Obidike, the State Commissioner for Health, exchanged views on relevant cooperation with a delegation from the NNRA. The delegation was led by Ekene Efenemoku, the NNRA's Southeast Zonal Coordinator. Efenemoku stated that the visit aimed to deepen bilateral cooperation and brief the state government on the NNRA's statutory responsibilities. According to his introduction, the...

2026-08-01

Russia's Vector Research Center Proposes Quantum Dots for Boron Delivery in Neutron Capture Therapy

Russia's Vector Research Center has proposed using quantum dots as targeted boron delivery systems in boron neutron capture therapy (BNCT) to explore more precise approaches to tumor treatment. Yuri Tumanov, the center's chief researcher, presented this research progress at a conference on engineering biology and biopharmaceuticals. Boron neutron capture therapy is a cancer treatment method that combines boron-containing drugs with neutron irradiation. The basic concept involves first allowing boron-containing drugs to accumulate in tumor cells, then subjecting the patient to neutron irradiation, which triggers a nuclear reaction that releases energy concentrated within boron-containing cancer cells, thereby destroying tumor cells. How to construct boron delivery systems that are low-toxicity, highly efficient, and capable of participating in targeted tumor destruction remains one of the key challenges in this field...

2026-08-01

Santa Casa Hospital in Ceará, Brazil, Introduces New Linear Accelerator for Cancer Treatment

Santa Casa de Sobral Hospital in northern Ceará, Brazil, has introduced a new linear accelerator to strengthen cancer treatment for patients in the northern region. The hospital received a new linear accelerator for radiotherapy of cancer patients. After completing the installation, training, and licensing processes, this new technology is expected to double the institution's radiotherapy capacity, increasing from the current 600 patients per month to approximately 1,200 new patients. This equipment, the Halcyon linear accelerator, is considered the latest technology in radiotherapy and is the second unit of its kind installed in Ceará. The device is capable of providing faster, more precise, and safer treatment for various types of cancer...

2026-08-01

Korea Hosts McSEE Dose Assessment Program Application Workshop to Enhance Radiation Emergency Medical Capabilities

The Korea Atomic Energy Research Institute announced that the National Radiation Emergency Medical Center recently held a workshop on the application of the Monte Carlo-based dose assessment program (McSEE) in the disaster prevention education and training room. This event is part of a research project to strengthen emergency care capabilities for radiation-injured patients, aiming to promote the application of new dose assessment technologies at radiation emergency sites and enhance the practical skills of medical staff and researchers. The workshop training was conducted by the research team of Professor Kim Chan-hyeong at Hanyang University. The team introduced the principles of Monte Carlo-based radiation dose assessment, the functions of the McSEE software and its application methods, and conducted case-based practical training around simulated radiation exposure accidents...

2026-08-01

Russian State Expert Review Authority Approves Design Changes for Ufa Radionuclide Therapy Center

Russia approves design changes for the Ufa Radionuclide Therapy Center, which will employ the latest technologies and equipment. The new center, located in the Republic of Bashkortostan, is expected to become a significant force in the local fight against cancer. With a floor area exceeding 6,000 square meters, the facility is a G-shaped three-story building with a basement. Its internal framework uses monolithic reinforced concrete to ensure stability and safety. The project's design strictly adheres to medical technology standards, aiming to create a modern and innovative treatment institution. At the core of the center is the radionuclide therapy department, which includes 24-hour inpatient wards, featuring a radionuclide supply area, a 20-bed "active" ward, and common areas. Additionally, it includes service and administrative zones to support the center's daily operations...

2026-08-01

Thor Medical Launches Commercial Production of Lead-212 at AlphaOne Facility

Thor Medical ASA announced on July 31 that commercial production has commenced at its industrial-scale AlphaOne production facility located in the Herøya industrial park. The facility will produce lead-212 (Pb-212) and its precursors thorium-228 (Th-228) and radium-224 (Ra-224) to support demand related to radiopharmaceuticals and targeted cancer radiotherapy. According to the company, Thor Medical has signed supply agreements with multiple types of customers across the radiopharmaceutical value chain, including startup biotechnology companies, contract development and manufacturing organizations (CDMOs), and global pharmaceutical companies. The company expects the AlphaOne facility to deliver its first products to customers in August 2026. AlphaOn...

2026-08-01

South Korea Plans to Establish Radioisotope Commercialization Company, Targeting Trial Production in 2028

According to sources inside and outside the South Korean government on July 31, Korea Hydro & Nuclear Power (KHNP) and relevant departments including the Ministry of Economy and Finance plan to discuss the establishment of a special purpose company (SPC) for radioisotope commercialization. The company is proposed to be set up as a subsidiary of KHNP, with domestic private enterprises, including pharmaceutical companies, expected to participate in investment. Under the current plan, the South Korean government will determine the specific investment structure and business plan through inter-departmental consultations this year, and strive to complete the company's establishment by 2027. Subsequently, the relevant parties will push forward facility construction to produce radioisotopes using nuclear power plants, with the goal of commencing trial production in 2028. Radioisot...

2026-08-01

Siemens Healthineers and Cleveland Clinic Launch 10-Year Strategic Alliance to Advance Innovation in Advanced Imaging and Radiation Oncology

On July 30, Siemens Healthineers and Cleveland Clinic announced the launch of a 10-year strategic alliance, building on their 35-year partnership to further drive clinical and workflow innovation, enhance patient care quality, and improve healthcare operational efficiency. Under the collaboration arrangement, Siemens Healthineers will provide Cleveland Clinic with a range of diagnostic imaging and treatment-related technologies, covering magnetic resonance imaging, computed tomography, radiation oncology, interventional radiology, and X-ray. Both parties stated that the alliance will focus on areas such as diagnostic imaging, cardiology, and radiation oncology, providing clinical teams with new tools and training support, and offering patients more...

2026-07-31

China Isotope & Radiation Corporation (CIRC) Conducts Cooperation Exchange with Guangzhou Tianhe District

On July 29, a delegation led by Tan Minghe, Secretary of the Guangzhou Tianhe District Party Committee, visited China Isotope & Radiation Corporation (CIRC) and held a meeting with Xiao Yafei, Secretary of the CIRC Party Committee and Chairman. The two sides conducted in-depth discussions on the establishment of CIRC's isotope and irradiation subsidiaries in Guangzhou's Tianhe District. Tan Minghe introduced the economic and social development of Tianhe District. He stated that as the central urban area and the top economic district of Guangzhou, Tianhe has ranked first in Guangzhou and among the top in the country for several consecutive years. Tianhe District has clearly included life and health as a key development track in modern urban industry, with nuclear medicine as a key focus area, which is highly aligned with isotope-related industries. Tianhe District will fully support the relocation of CIRC's isotope and irradiation subsidiaries to Guangzhou, providing high-quality business environment for their establishment and development. Yuan Xiaoyi, Deputy District Mayor of Tianhe, provided a detailed introduction on the development of the medical industry in Tianhe and the high compatibility of future industries such as nuclides and nuclear drugs with Tianhe's resources.

2026-07-31

Joint Safety Inspection of Directly Managed Nuclear Technology Utilization Units in Shandong by East China and North China Nuclear and Radiation Safety Supervision Stations

To thoroughly implement General Secretary Xi Jinping's important directive on the Quanzhou shoe factory fire accident, which calls for "in-depth investigation and rectification of various risk hazards, meticulous implementation of safety production measures, and resolute prevention of major and catastrophic accidents," the Ministry of Ecology and Environment's East China Nuclear and Radiation Safety Supervision Station (hereinafter referred to as the East China Station) recently joined forces with the North China Nuclear and Radiation Safety Supervision Station (hereinafter referred to as the North China Station) to take swift action. Together, they formed a joint inspection team to conduct safety inspections on some of the Ministry of Ecology and Environment's directly managed nuclear technology utilization units in Shandong Province. Shandong currently has 19 such units directly managed by the Ministry of Ecology and Environment, making it a major province in nuclear technology utilization. To ensure that this joint inspection achieves the goal of identifying...

2026-07-31

South Korean Study Confirms Low-Dose CT Arthrography Reduces Radiation Exposure in Shoulder Examinations

A research team led by Professor Choi Jeong-ah from the Department of Radiology at Hallym University Dongtan Sacred Heart Hospital in South Korea has recently confirmed that low-dose CT arthrography can reduce patient radiation exposure by approximately 31% while maintaining high diagnostic accuracy, with diagnostic performance comparable to 3T magnetic resonance imaging (3T MRI). The findings have been published in the international musculoskeletal imaging journal *Skeletal Radiology*. Rotator cuff tears and superior labral anterior-posterior (SLAP) lesions are significant causes of shoulder pain; if not diagnosed and treated in a timely manner, they may lead to arthritis or decreased shoulder joint function. Currently, 3T MRI is commonly used for precise examinations, but it has drawbacks such as high cost, long examination times, and the potential for claustrophobia in some patients;...

2026-07-30

Curium Advances Second Cyclotron Investment Plan in Romania to Expand PET Imaging Supply

On July 30, Curium announced that it is advancing its second cyclotron investment plan in Romania to expand access to advanced nuclear medicine services locally and further strengthen healthcare infrastructure. According to the introduction, after completing assessments of market opportunities, technical requirements, and regional infrastructure, Curium has identified the Cluj-Napoca region as the preferred site for the project and selected a preferred local partner. Preparatory work is currently underway to support the project's progression to the next phase. This expansion plan aims to increase relevant production capacity, enhance PET imaging equipment and service supply capabilities, improve patient access to advanced diagnostic procedures, and support the...

2026-07-30

TerraPower Isotopes to Donate Actinium-225 via Oncidium Foundation to Support Cancer Treatment Accessibility

TerraPower Isotopes (TPI), a subsidiary of U.S. nuclear innovation company TerraPower, announced on July 29 that it will coordinate the donation of the rare medical isotope actinium-225 (Ac-225) through the Oncidium Foundation to support economically disadvantaged cancer patients in accessing targeted radionuclide therapy. The Oncidium Foundation is a non-profit organization dedicated to promoting global access to targeted radionuclide cancer treatments. Its RLT-Connect program aims to help financially challenged patients access relevant therapies, reducing treatment disparities caused by geographic and economic conditions. This donation also marks TPI's entry into Oncidium's collaborative ecosystem of radioisotope suppliers, medical practitioners...

2026-07-30

International Students of the "Chinese Government Atomic Energy Scholarship" Program Visit China Isotope & Radiation Corporation

On July 22 and July 29, over 50 international students from more than 10 countries, including Egypt, Pakistan, Ethiopia, Ghana, the Philippines, Cambodia, Mongolia, Bangladesh, Namibia, Nigeria, El Salvador, Sudan, Yemen, and Russia, who are part of the Chinese Government Atomic Energy Scholarship program, visited China Isotope & Radiation Corporation (CIRC). They experienced firsthand the vibrant vitality of China's nuclear technology application industry, enhancing their understanding and recognition of China's nuclear industry through tours and exchanges. First Stop: Atomic High-Tech Jinhui Radiation - When Nuclear Technology Enters Daily Life. The students visited Atomic High-Tech Jinhui Radiation to learn about the extensive applications of irradiation technology in medical sterilization, food preservation, aerospace testing, and other fields, and observed relevant process flows. A student from Pakistan exclaimed, "I never imagined irradiation technology had penetrated so deeply into various fields. This has given me a completely new understanding of the breadth of China's nuclear technology applications." The students engaged in lively interactions with technical staff on topics such as the safety and application prospects of irradiation technology.

2026-07-30

Pre-registration Study Launch Meeting for Light Ion Therapy System Held in Hangzhou

On July 26, the pre-registration study launch meeting for the light ion therapy system was held at CAS Ion (Hangzhou) Medical Technology Co., Ltd. The meeting, themed "Focusing on Multi-ion Clinical Research, Empowering Precision Radiotherapy Innovation," discussed the frontier directions of multi-ion therapy, pre-registration study protocols for the therapy system, and related quality control work. The meeting was hosted by the Zhejiang Provincial Key Laboratory of Tumor Particle Radiotherapy Equipment and CAS Ion Hangzhou Company, and co-organized by the Sun Yat-sen University–CAS Ion (Lanzhou Taiji) Joint Laboratory of Advanced Radiotherapy Technology and the China-Japan-Korea Tumor Prevention and Control Research Institute. Experts and scholars from fields including clinical radiotherapy, medical physics, equipment R&D, and testing and evaluation...

2026-07-30

Moffitt Cancer Center Activates Proton Therapy Center in Florida, USA

Moffitt Cancer Center recently held a ribbon-cutting ceremony, announcing the official opening of the Richard M. Schultz Family Foundation Proton Center at the Moffitt Speros Outpatient Center. Located in the Speros Global R&D Park in Pasco County, Florida, it is recognized as the first proton therapy center in the Tampa Bay area. Moffitt Cancer Center stated that the activation of the proton therapy center will provide local patients with more precise radiotherapy options. Built in collaboration with IBA, a particle accelerator technology company, the center will use proton therapy to deliver targeted radiation to tumors, improving tumor targeting accuracy while minimizing impact on surrounding healthy tissues. According to reports, the...

2026-07-30

Ontario Invests Additional $4.6 Million in McMaster Nuclear Reactor to Expand Medical Isotope Production Capacity

The Government of Ontario, Canada, recently announced an additional investment of $4.6 million in the McMaster Nuclear Reactor to expand the production capacity of life-saving medical isotopes, supporting more cancer patients in accessing the critical radioisotopes needed for diagnosis and treatment. From left to right: Josip Zikic, Chief Nuclear Officer at McMaster University; Nolan Quinn, Minister of Colleges and Universities, Research Excellence and Security; Stephen Lecce, Minister of Energy and Mining; Susan Tighe, President and Vice-Chancellor of McMaster University; and Victor Fedeli, Minister of Economic Development, Job Creation and Trade. (Georgia Kirkos/McMaster University) This investment builds on a previous $18 million...

2026-07-30